FDA Inspection
Resilience US, Inc.Resilience US, Inc. – FDA Inspection, Mar 8, 2018
Record Details
This FDA Inspection record concerns Resilience US, Inc., with an inspection on March 8, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 5e71df58-ca79-476d-af51-50ceee60d664
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1043914
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Resilience US, Inc.
13| Date | Classification | Office | Project area |
|---|---|---|---|
| January 21, 2025 | VAI | Cincinnati District Office | Drug Quality Assurance |
| August 9, 2019 | VAI | Center for Devices and Radiological Health | New Drug Evaluation |
| September 7, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 27, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 24, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Resilience US, Inc.
- FDA Inspection 1258820 - 2025-01-21
- FDA Inspection 1099149 - 2019-08-09
- FDA Inspection 1028106 - 2017-09-07
- FDA Inspection 1018002 - 2017-06-27
- FDA Inspection 983420 - 2016-08-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.